Randomized Trial of Metformin With Anti-Tuberculosis Drugs for Early Sputum Conversion in Adults With Pulmonary Tuberculosis.

导出 OA

翻译打印收藏纠错

作者： Chandrasekaran,Padmapriydarsini ^[1] ; Megha,Mamulwar ^[2] ; Anant,Mohan ^[3] ; Prema,Shanmugam ^[1] ; N S,Gomathy ^[1] ; Aarti,Mane ^[2] ; Urvashi B,Singh ^[3] ; Nathella,Pavankumar ^[1] ; Abhijeet,Kadam ^[2] ; Hemanth,Kumar ^[1] ; Chandra,Suresh ^[1] ; Devaraju,Reddy ^[1] ; Poornaganga,Devi ^[1] ; P M,Ramesh ^[4] ; Lakshmanan,Sekar ^[1] ; Shaheed,Jawahar ^[5] ; R K,Shandil ^[5] ; Manjula,Singh ^[6] ; Jaykumar,Menon ^[5] ; Randeep,Guleria ^[3]

作者单位： Department of Clinical Research, Indian Council of Medical Research-National Institute for Research in Tuberculosis, Chennai, India. ^[1] Division of Data Management, Biostatistics and IT, Department of Clinical Research, Indian Council of Medical Research-National AIDS Research Institute, Pune, India. ^[2] Department of Pulmonary, Critical Care & Sleep Medicine, All India Institute for Medical Sciences, New Delhi, India. ^[3] Department of Thoracic Medicine, Government Ottery TB Hospital, Chennai, India. ^[4] Open Source Pharma Foundation, Bangalore, India. ^[5] Epidemiology and Communicable Diseases, Indian Council of Medical Research, New Delhi, India. ^[6]

关键词 host-directed therapy immunomodulation metformin pharmacokinetics tuberculosis